—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
Frontiers in Bioengineering and Biotechnology《生物工程与生物技术前沿》
年刊 - 瑞士
  • Frontiers in Bioengineering and Biotechnology《生物工程与生物技术前沿》
  • SCIE外文期刊
  • 期发文量1790
  • 国人占比50.48%
  • 知网外文库,维普目次
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:3区
    OA期刊:
  • 综述期刊:
    TOP期刊:
  • 期均国文:904
    环比增速:-43.50%
  • 期刊信息

  • 研究方向:工程技术-MULTIDISCIPLINARY SCIENCES综合性期刊
  • 国际刊号:ISSN 2296-4185;EISSN 2296-4185
  • 期刊语言:英语
    出版地区:瑞士
  • 投稿网址:https://www.frontiersin.org/submission/submit?domainid=1&fieldid=7&specialtyid=0&entitytype=2&entityid=452
  • 电子邮箱:
  • 期刊官网:https://www.frontiersin.org/journals/bioengineering-and-biotechnology
  • 作者指南:https://www.frontiersin.org/journals/bioengineering-and-biotechnology/for-authors/author-guidelines
  • 出版商网址:http://frontiersin.org
  • 出版地址:FRONTIERS MEDIA SA, AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015
  • 期刊简介:Frontiers in Bioengineering and Biotechnology《生物工程与生物技术前沿》(一年1卷). The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases.

  • 万维提示

  • 1、投稿方式:在线投稿

    2、期刊网址:

    https://www.frontiersin.org/journals/bioengineering-and-biotechnology

    3、投稿网址:

    https://www.frontiersin.org/submission/submit?domainid=1&fieldid=7&specialtyid=0&entitytype=2&entityid=452

    4、官网邮箱:bioengineering@frontiersin.org

    bioengineering.editorial.office@frontiersin.org

    5、期刊刊期:以Continuous publication形式出刊,一年出版1卷。

    2025年11月7星期五


欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 发表排期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码